ABT
ABBOTT LABORATORIES
NYSE · Healthcare · Medical - Devices · US
$108.32
−0.43%Forward multiples
Based on analyst estimates
- P/E forward
- 18.69x
- P/E 2026E
- 19.83x
- P/E 2027E
- 18.04x
- P/E 2028E
- 16.27x
- P/S forward
- 3.55x
Trailing multiples
Trailing twelve months
- P/E TTM
- 34.83x
- PEG TTM
- 0.41x
- Price / book
- 3.67x
- Price / sales
- 4.02x
- Price / cash flow
- 18.92x
Enterprise value
- Enterprise value
- $215.1B
- EV / sales
- 4.62x
- EV / EBITDA
- 21.63x
- EV / EBIT
- 27.12x
- Market cap
- $187.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026